"On August 15, 2014, Biogen Idec announced that the United States Food and Drug Administration (FDA) had approved Plegridy™ (peginterferon beta-1a) for the long-term treatment of relapsing forms of multiple sclerosis (MS). Manufactured by Biogen Idec, this new medication is the 11th disease-modifying therapy (DMT) to be approved for MS since the early 1990s. Plegridy is given once every two weeks through a subcutaneous self-injection."Click on link below for full article:
Temecula Group Meeting
The September Temecula MS Group Meeting will will be held on the 2nd Monday (9/8/14) due to Labor Day.
Resources, Seminars, & Support
Find resources near you in Southern CA.Dr. C. Smith, MD & the NMSS Pacific S. Coast Chapter for a free series of seminars to better manage MS symptoms & improve quality of life.
Wednesday, August 13, 2014
Managing MS-Related Fatigue
Wednesday, September 17, 2014
Below the Belt: Bladder, Bowel & Sexual Dysfunction
Wednesday, October 8, 2014
Managing Cognitive Challenges
Deadline to register is August 13 2014
Register by calling: 1-800-344-4867 press "1"
Date: Saturday, August 16, 2014
Time: 8:30 AM - 12:00 PM
Hilton San Diego Mission Valley
901 Camino Del Rio South
San Diego, CA 92108
Also download several PDFs at:www.nationalmssociety.org/Chapters/CAS/Find-Resources-and-Support?page=1&orderby=3&order=asc